Which laboratory test is most useful in determining whether to initiate an acute coronary syndrome protocol for a patient with chest pain?

• A. Troponin I level
• B. Creatine kinase MB level
• C. Myoglobin level
• D. C-reactive protein level

Answer: (A)

The main idea here is that troponin I is the most reliable indicator of myocardial injury to guide activation of an acute coronary syndrome protocol. Troponin I is highly specific to cardiac muscle, so when it enters the bloodstream it points to damage from a heart-related event, such as a myocardial infarction. It also remains elevated longer than many other markers, which helps clinicians confirm injury even if the patient’s chest pain has subsided and the ECG is equivocal.

Timing matters in chest pain evaluation. Troponin levels typically begin to rise within a few hours after injury, peak within about a day, and stay elevated for days, making it the most sensitive and specific biomarker for detecting ACS. In contrast, CK-MB is less specific because it can be elevated with skeletal muscle injury and other conditions; myoglobin rises early but is not specific to the heart; and C-reactive protein reflects inflammation and is not diagnostic of ACS. So, a rising troponin I level is the cornerstone that prompts initiation of ACS protocols and guides further management.